AU623080B2 - Use of an agent with a high affinity for tumours - Google Patents

Use of an agent with a high affinity for tumours Download PDF

Info

Publication number
AU623080B2
AU623080B2 AU18895/88A AU1889588A AU623080B2 AU 623080 B2 AU623080 B2 AU 623080B2 AU 18895/88 A AU18895/88 A AU 18895/88A AU 1889588 A AU1889588 A AU 1889588A AU 623080 B2 AU623080 B2 AU 623080B2
Authority
AU
Australia
Prior art keywords
tpa
fragment
agent
labelled
tumours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU18895/88A
Other languages
English (en)
Other versions
AU1889588A (en
Inventor
Hannu Aronen
Sirkka-Liisa Karonen
Jan Lindgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU1889588A publication Critical patent/AU1889588A/en
Application granted granted Critical
Publication of AU623080B2 publication Critical patent/AU623080B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Steroid Compounds (AREA)
AU18895/88A 1987-07-08 1988-07-08 Use of an agent with a high affinity for tumours Ceased AU623080B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3722522 1987-07-08
DE19873722522 DE3722522A1 (de) 1987-07-08 1987-07-08 Verwendung eines vehikels mit hoher affinitaet zu tumoren

Publications (2)

Publication Number Publication Date
AU1889588A AU1889588A (en) 1989-01-12
AU623080B2 true AU623080B2 (en) 1992-05-07

Family

ID=6331118

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18895/88A Ceased AU623080B2 (en) 1987-07-08 1988-07-08 Use of an agent with a high affinity for tumours

Country Status (13)

Country Link
EP (1) EP0298436B1 (enrdf_load_stackoverflow)
JP (1) JPH01125331A (enrdf_load_stackoverflow)
KR (1) KR890001508A (enrdf_load_stackoverflow)
AT (1) ATE81473T1 (enrdf_load_stackoverflow)
AU (1) AU623080B2 (enrdf_load_stackoverflow)
DE (2) DE3722522A1 (enrdf_load_stackoverflow)
DK (1) DK167561B1 (enrdf_load_stackoverflow)
ES (1) ES2046244T3 (enrdf_load_stackoverflow)
FI (1) FI883177A7 (enrdf_load_stackoverflow)
GR (1) GR3006404T3 (enrdf_load_stackoverflow)
NO (1) NO883040L (enrdf_load_stackoverflow)
NZ (1) NZ225350A (enrdf_load_stackoverflow)
ZA (1) ZA884870B (enrdf_load_stackoverflow)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663146A (en) * 1983-07-29 1987-05-05 Codon Genetic Engineering Laboratories Methods and compositions for the diagnosis of bloodclots using plasminogen activator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663146A (en) * 1983-07-29 1987-05-05 Codon Genetic Engineering Laboratories Methods and compositions for the diagnosis of bloodclots using plasminogen activator

Also Published As

Publication number Publication date
KR890001508A (ko) 1989-03-27
NO883040L (no) 1989-01-09
ZA884870B (en) 1989-04-26
ATE81473T1 (de) 1992-10-15
AU1889588A (en) 1989-01-12
EP0298436A2 (de) 1989-01-11
DE3875290D1 (de) 1992-11-19
NZ225350A (en) 1991-07-26
GR3006404T3 (enrdf_load_stackoverflow) 1993-06-21
ES2046244T3 (es) 1994-02-01
FI883177L (fi) 1989-01-09
DK377588A (da) 1989-01-09
DE3722522A1 (de) 1989-01-19
DK377588D0 (da) 1988-07-07
DK167561B1 (da) 1993-11-22
FI883177A7 (fi) 1989-01-09
NO883040D0 (no) 1988-07-07
EP0298436A3 (en) 1990-01-17
FI883177A0 (fi) 1988-07-04
EP0298436B1 (de) 1992-10-14
JPH01125331A (ja) 1989-05-17

Similar Documents

Publication Publication Date Title
Markus et al. Content and characterization of plasminogen activators in human lung tumors and normal lung tissue
Rabbani et al. Prevention of prostate‐cancer metastasis in vivo by a novel synthetic inhibitor of urokinase‐type plasminogen activator (uPA)
DE69836199T2 (de) Anti-invasive and anti-angiogene urokinase fragmente und deren verwendung
KR20140085569A (ko) 치료제 및 이의 용도
US20090311174A1 (en) Method For Treating Cancer
EP1064005B1 (en) Urokinase plasminogen activator receptor as a target for diagnosis of micrometastases
Eiber et al. 18F-rhPSMA-7 positron emission tomography for the detection of biochemical recurrence of prostate cancer following radical prostatectomy
Soltay et al. The kinin system of human plasma V. The probable derivation of prekallikrein activator from activated Hageman factor (XIIa)
JPH0372894A (ja) 悪性腫瘍細胞の検出
Guo et al. A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging
CA2406882A1 (en) Diagnostic probes and therapeutics targeting upa and upar
AU623080B2 (en) Use of an agent with a high affinity for tumours
CN1325639C (zh) 高纯度蚓激酶的制备方法及由其制备的药物制剂
EP3922265A1 (en) Humanized anti psa (5a10) antibodies
DE69018361T2 (de) Phosphorylierte plasminogenaktivatoren.
CN114558122A (zh) 放射核素标记的过氧化氢酶及其应用
JP4880854B2 (ja) 高い免疫反応性を有するタンパク質及びその製造方法
US6896870B1 (en) Diagnostic probes and therapeutics targeting uPA and uPAR
JP2003523400A (ja) 癌治療用および画像化用ｐａｉ−２接合体
US20070128196A1 (en) Methods and compositions for inhibiting angiogenesis
JPH04507254A (ja) 線維素溶解活性検出用試薬
AU594496B2 (en) The use of monoclonal antibodies for the therapy of tumors
Mariani et al. Tissue distribution of radiolabeled anti-CEA monoclonal antibodies in man
Casper et al. Biological study of R24 mouse monoclonal antibody in patients undergoing thoracotomy for pulmonary metastases from soft tissue sarcoma
JP3129430B2 (ja) リン酸化ウロキナーゼの測定方法